Vaxart Inc (NQ: VXRT )
0.8552
+0.0032
(+0.38%)
Streaming Delayed Price
Updated: 12:47 PM EDT, Aug 30, 2024
Add to My Watchlist
All News about Vaxart Inc
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2047.jpeg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/girl-2581913_1_1.jpg?width=720)
![](https://investorplace.com/wp-content/uploads/2020/09/vxrt-stock-1.jpg)
![](https://images.pexels.com/photos/5849595/pexels-photo-5849595.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
Wingstop, Akamai Initiations Among Today's Top Calls On Wall Street
December 29, 2021
Via Talk Markets
![](https://investorplace.com/wp-content/uploads/2020/09/vxrt-stock-1.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/face-mask-gcd59977aa_1280.png?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_107.jpg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/syringe-866550_1920_8.jpg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2898.png)
![](https://investorplace.com/wp-content/uploads/2020/09/vxrt-stock-1.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/airplane-3149285_1920_17_26.jpg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/chart-840331_1920_80.jpg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_2249.jpeg?width=720)
![](https://investorplace.com/wp-content/uploads/2020/09/vxrt-stock-1.jpg)
![](https://g.foolcdn.com/editorial/images/646720/gettyimages-1286862956.jpg)
Can This COVID Vaccine Stock Help Make You Rich?
October 16, 2021
Via The Motley Fool
Exposures
COVID-19
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-5103043_1920_47.jpg?width=720)
NASDAQ:VXRT Investor Alert: Update in Lawsuit Against Vaxart, Inc.
October 12, 2021
Via SBWire
Topics
Lawsuit
![](https://g.foolcdn.com/editorial/images/646040/gettyimages-88689535.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/50589668142_a9f9b8b5c9_c.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_465.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/50770420066_5b01eba40e_c.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_2659.jpeg?width=720)
![](https://g.foolcdn.com/editorial/images/645881/oral-medications.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2130.png)
![](https://investorplace.com/wp-content/uploads/2021/05/vaxart_vxrt_1600_d.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/microscope-3184432_1920_217.jpg)
![](https://investorplace.com/wp-content/uploads/2021/06/vaccine-covid-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2020/09/vxrt-stock-1.jpg)
As the Virus Continues, the Global Covid-19 Vaccine Market Expected to Reach $25 Billion By 2024
September 23, 2021
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.